The price you pay for Vowst may depend on factors such as your dosage, whether you have health insurance, and the pharmacy you use. Financial assistance may be available to help you with the cost ...

The cost of Vowst can vary based on several factors, including your insurance coverage. Coupons and drug savings programs can also lower the price you’ll pay for Vowst. your treatment plan your ...

Detailed price information for Seres Therapeutics Inc (MCRB-Q) from The Globe and Mail including charting and trades.

Q4 2024 Earnings Call Transcript March 13, 2025 Seres Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.1, ...

Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed primary efficacy endpoint of reduction in bloodstream inf ...

Clostridioides difficile (C. difficile) infection (CDI) is a significant healthcare-associated infection, known for its high morbidity and mortality ...

These acquisitions were executed at no cost, reflecting the conversion of ... the transition obligations following the sale of Seres' VOWST business. The company expects an additional $25 million ...

Eric Shaff; President, Chief Executive Officer, Director; Seres Therapeutics Inc Lisa von Moltke; Executive Vice President, Chief Medical Officer; Seres Therapeutics Inc Matthew Henn; Executive Vice ...

Erythromycin is a generic drug prescribed for certain bacterial infections. The cost of erythromycin with and without insurance can depend on several factors, such as whether there’s financial ...

Seres led the successful development and approval of VOWST™, the first FDA-approved orally administered microbiome therapeutic, which was sold to Nestlé Health Science in September 2024.

rather than from the donor-sourced production process used for VOWST. In addition to allo-HSCT, the Company intends to evaluate SER-155 and other cultivated live biotherapeutic candidates in other ...